Edgestream Partners’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.92M | Sell |
39,740
-10,096
| -20% | -$2.52M | 0.29% | 67 |
|
|
2025
Q4 | $12M | Buy |
+49,836
| New | +$12.7M | 0.34% | 40 |
|
|
2025
Q3 | – | Sell |
-1,769
| Closed | -$456K | – | 1032 |
|
|
2025
Q2 | $456K | Sell |
1,769
-20,650
| -92% | -$4.93M | 0.01% | 741 |
|
|
2025
Q1 | $5.02M | Buy |
+22,419
| New | +$5.23M | 0.17% | 222 |
|
|
2024
Q4 | – | Sell |
-1,568
| Closed | -$383K | – | 1046 |
|
|
2024
Q3 | $383K | Buy |
+1,568
| New | +$350K | 0.02% | 736 |
|
|
2023
Q4 | – | Sell |
-3,826
| Closed | -$566K | – | 1031 |
|
|
2023
Q3 | $566K | Sell |
3,826
-270
| -7% | -$48.8K | 0.05% | 569 |
|
|
2023
Q2 | $895K | Sell |
4,096
-5,729
| -58% | -$1.28M | 0.08% | 381 |
|
|
2023
Q1 | $2.15M | Sell |
9,825
-3,476
| -26% | -$754K | 0.24% | 131 |
|
|
2022
Q4 | $2.77M | Buy |
+13,301
| New | +$2.92M | 0.31% | 92 |
|
|
2022
Q3 | – | Sell |
-6,660
| Closed | -$1.4M | – | 586 |
|
|
2022
Q2 | $1.4M | Buy |
6,660
+977
| +17% | +$208K | 0.11% | 266 |
|
|
2022
Q1 | $1.38M | Sell |
5,683
-10,680
| -65% | -$2.58M | 0.11% | 273 |
|
|
2021
Q4 | $4.26M | Buy |
16,363
+13,408
| +454% | +$3.48M | 0.27% | 114 |
|
|
2021
Q3 | $779K | Buy |
2,955
+680
| +30% | +$186K | 0.05% | 351 |
|
|
2021
Q2 | $561K | Sell |
2,275
-23,631
| -91% | -$4.97M | 0.03% | 341 |
|
|
2021
Q1 | $5.03M | Sell |
25,906
-8,359
| -24% | -$1.68M | 0.28% | 142 |
|
|
2020
Q4 | $7.28M | Sell |
34,265
-44,967
| -57% | -$8.97M | 0.37% | 87 |
|
|
2020
Q3 | $13.6M | Sell |
79,232
-139,072
| -64% | -$25.7M | 0.88% | 29 |
|
|
2020
Q2 | $41.9M | Buy |
218,304
+60,662
| +38% | +$9.92M | 2.2% | 2 |
|
|
2020
Q1 | $23.2M | Sell |
157,642
-36,044
| -19% | -$5.74M | 2.15% | 2 |
|
|
2019
Q4 | $30M | Buy |
193,686
+98,236
| +103% | +$14.2M | 1.56% | 9 |
|
|
2019
Q3 | $12.9M | Buy |
95,450
+35,460
| +59% | +$4.65M | 1.23% | 17 |
|
|
2019
Q2 | $7.32M | Sell |
59,990
-23,611
| -28% | -$2.62M | 0.83% | 42 |
|
|
2019
Q1 | $8.69M | Buy |
+83,601
| New | +$8.63M | 1.28% | 20 |
|
|
2018
Q4 | – | Sell |
-6,008
| Closed | -$693K | – | 286 |
|
|
2018
Q3 | $693K | Buy |
+6,008
| New | +$658K | 0.12% | 168 |
|
|
2018
Q2 | – | Sell |
-2,918
| Closed | -$287K | – | 288 |
|
|
2018
Q1 | $287K | Buy |
+2,918
| New | +$276K | 0.06% | 223 |
|
Other funds holding RMD
VCM
VPM
DAM
Edgestream Partners's RMD Position: Q1 2026 in Review
Edgestream Partners reduced its ResMed (RMD) stake by 20% in Q1 2026, selling an estimated $2.52M and leaving 39,740 shares worth $8.92M. The position accounts for 0.29% of the portfolio, ranked #67.
Edgestream Partners first reported a position in RMD in Q1 2018 and has held it in 25 quarters since. The position peaked at $41.9M in Q2 2020. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Edgestream Partners held 39,740 shares of ResMed worth $8.92M as of Q1 2026.
- Edgestream Partners sold 10,096 ResMed shares in Q1 2026, an estimated $2.52M.
- ResMed made up 0.29% of Edgestream Partners's portfolio in Q1 2026, its #67 holding.
- Edgestream Partners first reported a position in ResMed in Q1 2018 and has held it in 25 quarters since.
- Edgestream Partners's ResMed position peaked at $41.9M in Q2 2020.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Edgestream Partners's 13F filing for Q1 2026, filed 18 May 2026.